Appointment | December 22, 2021
Windlas Biotech appoints Shailendra Rastogi as CBO
He has over 22 years of experience in pharmaceutical sales & business development
He has over 22 years of experience in pharmaceutical sales & business development
Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Acquisition will add GT005 to the Novartis portfolio, an investigational, one-time gene therapy currently in Phase 2 for the treatment of people living with Geographic atrophy
The company has started manufacturing the Sputnik Light vaccine
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
The capsules are the generic version of the reference listed drug Mycobutin
It is indicated for the treatment of patients with acromegaly and Gastroenteropancreatic Neuroendocrine Tumours
2022 is going to be the year of opportunities and innovations from the medical industry in India
The study was performed independently by investigators at the US Food and Drug Administration (FDA), Center for Biologics Evaluation and Research
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Subscribe To Our Newsletter & Stay Updated
